STOCK TITAN

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Milestone Pharmaceuticals (Nasdaq: MIST) announced that Joseph Oliveto, President and CEO, will present at two key investor conferences. The first is the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on September 15, 2020, at 11:30 a.m. ET. The second is the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23, 2020, at 2:30 p.m. ET. Live webcasts of the presentations will be available on Milestone's website, with archived replays accessible for 30 days post-event.

Positive
  • None.
Negative
  • None.

MONTREAL and CHARLOTTE, N.C., Sept. 8, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

  • The H.C. Wainwright & Co. 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time
  • The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23, 2020 at 2:30 p.m. Eastern Time

A live webcast of the presentations can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcasts will be available on the same website for approximately 30 days following the presentations.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

 

(PRNewsfoto/Milestone Pharmaceuticals)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301124643.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

When will Milestone Pharmaceuticals present at the H.C. Wainwright conference?

Milestone Pharmaceuticals will present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on September 15, 2020, at 11:30 a.m. Eastern Time.

What date is Milestone Pharmaceuticals presenting at the Oppenheimer Summit?

Milestone Pharmaceuticals will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23, 2020, at 2:30 p.m. Eastern Time.

How can I watch the Milestone Pharmaceuticals presentations?

You can watch the Milestone Pharmaceuticals presentations via live webcast in the News & Events section of their website.

Where can I find archived replays of Milestone Pharmaceuticals' presentations?

Archived replays of Milestone Pharmaceuticals' presentations will be available on their website for approximately 30 days after the events.

What is the stock symbol for Milestone Pharmaceuticals?

The stock symbol for Milestone Pharmaceuticals is MIST.

Milestone Pharmaceuticals Inc. Common Shares

NASDAQ:MIST

MIST Rankings

MIST Latest News

MIST Stock Data

82.04M
53.27M
0.69%
56.84%
0.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MONTREAL